$2.5 million awarded to Princess Alexandra Hospital and Griffith University in Queensland to establish the ACRF Centre for High-Risk Breast Cancer.
ACRF funding will provide a world leading magnetic resonance (MR) scanner that can detect warning chemical changes in breast tissue years before cancer appears.
For the thousands of Australian women at high genetic risk of breast cancer, this breakthrough technology has the potential to act as a real-time risk predictor: helping to identify exactly who may be susceptible and who may safely avoid preventative surgery or strong medication. The non-invasive, contrast-free scan could also offer an alternative for measuring breast density in women who may not be able to tolerate standard contrast agents.
The centre will run national clinical trials for best managing women at risk for breast cancer. The goal is to make this lifesaving early-detection system available across Australia and internationally. Scans will also be offered to patients to assess the risk of ovarian cancer.